Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1990-09-10
1991-10-22
Dentz, Bernard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
5142302, 514294, 514300, 514312, 544 32, 544101, 546 94, 546123, 546156, A61K 31435, A61K 3147, C07D47104, C07D21556
Patent
active
050595970
ABSTRACT:
7-(1-Pyrrolidinyl)-3-quinolone- and -naphthyridone-carboxylic acid derivatives as antibacterial agents and feed additives, of the formula ##STR1## in which X.sup.1 is halogen,
REFERENCES:
patent: 4668784 (1987-05-01), Mascellani et al.
patent: 4777175 (1988-10-01), Culbertsen et al.
Liebig's Ann. der Chemie, vol. 677 (1964), p. 155.
Chemical Abstracts, vol. 104, 1986, p. 521, 50861t.
Chemical Abstracts, vol. 111, 1989, p. 742, 97210q.
Chemical Abstracts, vol. 111, 1989, p. 721, 153779w.
Journal of Medicinal Chemistry, vol. 27, No. 12, Dec. 1984, pp. 1543-1549, American Chemical Society.
Endermann Rainer
Grohe Klaus
Haller Ingo
Krebs Andreas
Metzger Karl G.
Bayer Aktiengesellschaft
Dentz Bernard
LandOfFree
7-(4-oxa or 4-thia-2,7-diazabicyclo[3.3.0]oct-2-en-3-yl)-3-quino does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 7-(4-oxa or 4-thia-2,7-diazabicyclo[3.3.0]oct-2-en-3-yl)-3-quino, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 7-(4-oxa or 4-thia-2,7-diazabicyclo[3.3.0]oct-2-en-3-yl)-3-quino will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-108646